Bixiye
QP58-18 Pharmacy Benefit Exclusion for Cytovene, Foscavir, Prevymis, Trogarzo, Vistide and Zovirax
Taariikhda dhaqangalka Barnaamijka: Jul 19, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2821 - 2830 ee natiijooyinka 3167
Bixiye
QP56-18 Availity Authorization Portal Update
Taariikhda dhaqangalka Barnaamijka: Jul 18, 2018
Bixiye
P31-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective September 3, 2018
Taariikhda dhaqangalka Barnaamijka: Jul 02, 2018
Bixiye
P27-18 New Site of Care Drug Management Program for Infused and Injectable Drugs Administered by a Health Care Provider
Taariikhda dhaqangalka Barnaamijka: Jul 02, 2018
Bixiye
2018 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 02, 2018
Bixiye
QP54-18 Medical Drug Exclusion Lists Expanded to Include Synojoynt
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018
Bixiye
QP55-18 New Drug - Epidiolex (cannabidiol) will Require Prior Authorization
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018
Bixiye
P30-18 New Fully Insured Commercial Medication Therapy Management Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018
Bixiye
P31-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective September 3, 2018
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018
Bixiye
P28-18 Change to Administration of Interpreter Services for MHCP Subscribers
Taariikhda wax ku ool ah ee barnaamijka: Jun 28, 2018